Researchers from Synlogic are testing a synthetic biology-based treatment for phenylketonuria, according to the New York Times.
The Intelligence Advanced Research Projects Activity has amassed a team to spot DNA orders that could be used in bioweapons, Bloomberg reports.
A new report highlights the potential threats posed by advances in synthetic biology, NPR reports.
The New York Times reports that biohackers are also concerned about the potential harms of DIY genetic engineering.
The Genome Project–write leaders propose the development of virus-resistant cells, according to Science.
The award expands an existing collaboration between the firms for automated organism design.
ExxonMobil and Synthetic Genomics are moving forward with their exploration of algae-based biofuels, the San Diego Union-Tribune reports.
In Science this week: genetic overlap between five psychiatric disorders, and more.
The company, which was founded in 2016, said it would use the funding to further develop its core gene synthesis platform.
DNA Script has acquired an exclusive license to a novel DNA building block for use in enzymatic DNA synthesis.
CBS This Morning highlights recent Medicare fraud involving offers of genetic testing.
Researchers find that many cancer drugs in development don't work quite how their developers thought they did, as Discover's D-brief blog reports.
Mariya Gabriel, a Bulgarian politician, is to be the next European Union research commissioner, according to Science.
In Science this week: a survey indicates that US adults are more likely to support the agricultural use of gene drives if they target non-native species and if they are limited, and more.